Liposomal-lupane system as alternative chemotherapy against cutaneous leishmaniasis: macrophage as target cell.

Author: BarrosNeuza B, CiancagliniPietro, FacundoValdir A, MigliaccioVanessa, NicoleteRoberto, Silva-JardimIzaltina, StábeliRodrigo G

Paper Details 
Original Abstract of the Article :
Leishmania amazonensis causes human diseases that range from self-healing to diffusion cutaneous lesions. The chemotherapy of leishmaniasis requires long-term treatment and has been based on the use of pentavalent antimonials. Liposomes have been used as antileishmanial drug carries and have adjuvan...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1016/j.exppara.2013.07.022

データ提供:米国国立医学図書館(NLM)

Liposomal-Lupane System for Cutaneous Leishmaniasis

The vast desert of tropical medicine presents unique challenges. This research focuses on cutaneous leishmaniasis, a parasitic disease that causes skin lesions. The study investigates a novel approach for treating the disease, utilizing a liposomal formulation containing lupane, a natural compound with anti-leishmanial properties.

Liposomal-Lupane System: A New Therapeutic Strategy

The researchers developed a liposomal formulation containing lupane, a natural compound isolated from the fruits of Combretum leprosum. This is like encasing a potent medicinal ingredient in a protective capsule, ensuring its safe and effective delivery to the target area. The study evaluated the efficacy of liposomal-lupane in a mouse model of Leishmania amazonensis infection.

Implications for Leishmaniasis Treatment

This research presents a promising new approach for treating cutaneous leishmaniasis. The liposomal-lupane system, like a skilled desert traveler carrying a precious remedy, could offer a more effective and potentially safer treatment option, reducing the need for long-term and often toxic treatments.

Dr. Camel's Conclusion

This study explores a new frontier in the treatment of cutaneous leishmaniasis. The liposomal-lupane system offers a beacon of hope in the desert of parasitic diseases, potentially leading to improved therapeutic strategies and enhanced patient outcomes.
Date :
  1. Date Completed 2013-12-05
  2. Date Revised 2013-10-14
Further Info :

Pubmed ID

23933281

DOI: Digital Object Identifier

10.1016/j.exppara.2013.07.022

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.